| PUBCHEM ID |
119025995
|
| UNII |
RBA4DGT17A
|
| Preferred Term |
1-(PHENYLMETHYL) N-(N-(((4-METHOXYPHENYL)METHOXY)CARBONYL)-L-.ALPHA.-ASPARTYL)-L-PHENYLALANATE
|
| CAS |
118203-05-7
|
| INCHIKEY |
HZIRKKLDMQBHQR-DQEYMECFSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
COc1ccc(COC(N[C@@H](CC(O)=O)C(N[C@@H](Cc2ccccc2)C(OCc2ccccc2)=O)=O)=O)cc1
|
| Total Surface Area |
415,35
|
| Relative PSA |
0,28453
|
| TPSA |
140,26
|
| cLogS |
-4,736
|
| MW |
534,563
|
| cLogP |
2,6042
|
| H-Acceptors |
10
|
| H-Donors |
3
|
| Ro5 violations |
1
|
| Druglikeness |
-9,1925
|
| DrugScore |
0,262154377682889
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA-
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
-0,1353
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,4578
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,2296
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,3077
|
| Carcinogenicity (Three-class) |
Non-required
|
